Progyny, Inc. (PGNY) Stock Grade

About Progyny, Inc.'s fundamentals

Progyny operates as a healthcare information services company with a $2.2 billion market capitalization and has demonstrated moderate revenue growth of 10.4% year-over-year. The company maintains a net profit margin of 4.5%, indicating that roughly 4.5 cents of each revenue dollar converts to net income, though this remains relatively lean for the healthcare sector. Trading at a P/E ratio of 37.4, investors are paying a premium multiple relative to current earnings, while the company generates an 11.3% return on equity. The company does not currently pay a dividend, directing retained earnings toward growth or other capital allocation priorities.